Revenio Group Oyj (LON:0KFH)

Market Cap	360.31M -31.7%
Revenue (ttm)	107.07M +16.0%
Net Income	11.29M -27.5%
EPS	0.41 -27.2%
Shares Out	n/a
PE Ratio	20.31
Forward PE	16.69
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4
Open	10.45
Previous Close	10.32
Day's Range	10.00 - 10.45
52-Week Range	10.00 - 22.70
Beta	1.38
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 12, 2026

About Revenio Group Oyj

Revenio Group Oyj, provides ophthalmological devices and software solutions for the diagnosis of glaucoma, macular degeneration, and diabetic retinopathy in Finland, the United States, and internationally. The company offers iCare IC100, ST500, and IC200 tonometers; iCare HOME2, a tonometer to measure eye pressure; iCare Sensors that are accessories of iCare tonometer for measuring intraocular pressure (IOP); iCare TONOVET Pro, a tonometer designed for use in surgical or emergency settings; and iCare TONOVET Plus tonometer, which is used by vet...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2001
• Employees: 765
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0KFH

Financial Performance

In 2025, Revenio Group Oyj's revenue was 109.85 million, an increase of 5.80% compared to the previous year's 103.82 million. Earnings were 17.41 million, a decrease of -5.87%.

Financial numbers in EUR

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Nov 10, 2026

Data Sources Report a data error